News
People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of ...
People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...
Most adults with acromegaly reduced IGF-1 levels and improved acromegaly symptoms with once-monthly subcutaneous octreotide ...
1d
Clinical Trials Arena on MSNCrinetics reveals new data from acromegaly therapy programmeThe Palsonify-treated subjects maintained control, with stable growth hormone levels, symptom scores, and pituitary tumour ...
1d
Stocktwits on MSNCrinetics Pharma’s Oral Drug Shows Lasting Relief For Acromegaly Patients In Latest Study; Retail Buzz BuildsRetail chatter around Crinetics Pharmaceuticals picked up late Sunday after the company released long-term data for its oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results